Skip to main content

Mechanisms of Venous Graft Failure

  • Chapter
  • First Online:
Coronary Graft Failure

Abstract

Venous graft failure is a complex pathology of surgical revascularization that comprises many physiopathologic mechanisms, some of them still unclear until the present moment. Arterialization of the venous graft produces structural modifications in the graft wall, including all anatomic layers: intima, media, and adventitia. Of these, the most important aspect of graft dysfunction is intimal destructuration by various mechanisms: endothelial cell separation and cell loss, intimal edema, exposed basement membrane, subendothelial collagen and elastin, intimal tears and flaps, fibrointimal hyperplasia, neointimal hyperplasia, and thrombus formation. Some of these pathogenic processes are exacerbated while others are diminished, but, overall, they lead to graft restenosis. Intimal edema extends toward the superjacent layer, producing myocite necrosis, fibrosis, and eventually aneurysm formation. Adventitial ischemia produced by graft harvesting determines vasa vasorum loss and vein sclerosis. Under these circumstances, neoangiogenesis occurs without oxygenation importance criteria, which leads to augmentation of neointimal hyperplasia and intimal and medial fibrosis. Therefore, graft restenosis is a complex process with many pathologic mechanisms, in general without sequentiality, but which taken together lead toward what is designated as “venous graft disease.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shuhaiber JH, Evans AN, Massad MG, Geha AS. Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothorac Surg. 2002;22(3):387–96.

    Article  PubMed  Google Scholar 

  2. Campeau L, Enjalbert M, Lesperance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984;311(21):1329–32.

    Article  CAS  PubMed  Google Scholar 

  3. Bourassa MG. Fate of venous grafts: the past, the present, and the future. J Am Coll Cardiol. 1991;5(5):1081–3.

    Article  Google Scholar 

  4. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616–26.

    Article  CAS  PubMed  Google Scholar 

  5. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44(11):2149–56.

    Article  PubMed  Google Scholar 

  6. Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol. 2005;96(9):1254–9.

    Article  PubMed  Google Scholar 

  7. Brilakis ES, Wang T, Rao SV, et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. JACC Cardiovasc Interv. 2010;3(10):1068–73.

    Article  PubMed  Google Scholar 

  8. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, et al. Saphenous vein graft intervention. JACC Cardiovasc Interv. 2011;4(8):831–43.

    Article  PubMed  Google Scholar 

  9. Widimsky P, Straka Z, Stros P. One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation. 2004;110:3418–23.

    Article  PubMed  Google Scholar 

  10. Alexander JH, Hafley G, Harrington RA, PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–54.

    Article  PubMed  Google Scholar 

  11. Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts gave an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004;109:2086–91.

    Article  PubMed  Google Scholar 

  12. Shroyer AL, Grover FL, Hattler B, ROOBY Study Group. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361:1827–37.

    Article  CAS  PubMed  Google Scholar 

  13. Goldman S, Zadina K, Moritz T; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.

    Google Scholar 

  14. LoGerfo FW, Quist WC, Cantelmo NL, Haudenschild CC. Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation. 1983;68:II117–24.

    Article  CAS  PubMed  Google Scholar 

  15. Zwolak RM, Adams MC, Clowes AW. Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg. 1987;5:126–36.

    Article  CAS  PubMed  Google Scholar 

  16. Groves HM, Kinlough-Rathbone RL, Mustard JF. Development of non-thombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Arteriosclerosis. 1986;6:189–95.

    Article  CAS  PubMed  Google Scholar 

  17. Linder V, Reidy MA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106–13.

    Article  Google Scholar 

  18. Heine G, Ulrich C, Sester U, Sester M, Köhler K, Girndt M. Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis. Kidney Int. 2003;64:1101–7.

    Article  CAS  PubMed  Google Scholar 

  19. Kaiura T, Itoh H, Kubaska S, McCaffrey T, Liu B, Kent K. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg. 2000;31:577–84.

    Article  CAS  PubMed  Google Scholar 

  20. Lemson M, Tordoir J, Daemen M, Kitslaar P. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg. 2000;19:336–50.

    Article  CAS  PubMed  Google Scholar 

  21. Budu-Grajdeanu P, Schugart RC, Friedman A, Valentine C, Agarwal AK, Rovin BH. A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model. 2008;5:2. doi:10.1186/1742-4682-5-2.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Scherer C, Pfisterer L, Wagner AH, Hödebeck M, Cattaruzza M, Hecker M, Korff T. Arterial Wall stress controls NFAT5 activity in vascular smooth muscle cells. J Am Heart Assoc. 2014;3:e000626, originally published March 10, 2014 doi: 10.1161/JAHA.113.00062.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol. 2006;84:115–24 [PubMed].

    Article  CAS  PubMed  Google Scholar 

  24. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 2001;81:999–1030 [PubMed].

    CAS  PubMed  Google Scholar 

  25. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Div Biol. 1997;13:261–91.

    Article  CAS  Google Scholar 

  26. SGeorge SJ, Zaltsman AB, Newby AC. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc Res. 1997;33:447–59.

    Article  Google Scholar 

  27. Kranzhofer A, Baker AH, George SJ, Newby AC. Expression of tissue inhibitor of metalloproteinase-1,-2, and-3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb Vasc Biol. 1999;9:255–65.

    Article  Google Scholar 

  28. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest. 1998;101(6):1478–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Dummler S, Eichhorn S, Tesche C, Schreiber U, Voss B, Deutsch MA, Hauner H, Lahm H, Lange R, Krane M. Pulsatile ex vivo perfusion of human saphenous vein grafts under controlled pressure conditions increases MMP-2 expression. Biomed Eng Online. 2011;10:62. http://www.biomedical-engineering.online.com/content/10/1/62.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res. 1985;57(1):105–12.

    Article  CAS  PubMed  Google Scholar 

  31. Engler RL, Dahlgen MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:H314–22.

    CAS  PubMed  Google Scholar 

  32. Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, Brett J, Wolitzky BA, Norton C, Plocinski J, Benjamin W. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992;90:2333–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis. 1991;34:45–68.

    Article  CAS  PubMed  Google Scholar 

  34. Perek B, Malinska A, Stefaniak S, Ostalska-Nowicka D, Misterski M, et al. Predictive factors of late venous Aortocoronary graft failure: Ultrastructural studies. PLoS One. 2013;8(8):e70628. doi:10.1371/journal.pone.0070628. PLoS One, Edited by Luca Testa, vol. 8, issue 8, p. e70628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease a critical appraisal. Circulation. 2005;112:1813–24.

    Article  PubMed  Google Scholar 

  36. Ishida M, Komori K, Yonemitsu Y, Taguchi K, Onohara T, Sugimachi K. Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal run-off. Implications of vein graft remodeling. Atherosclerosis. 2001;154(2):345–54.

    Article  CAS  PubMed  Google Scholar 

  37. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97(9):916–31. Acesteparticularitati structural ale placii de aterompredispun la trombozasimicroembolizaredistala (Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117(6):790–7).

    Article  CAS  PubMed  Google Scholar 

  38. Sarjeant JM, Rabinovitch M. Understanding and treating vein graft atherosclerosis. Cardiovasc Pathol. 2002;11(5):263–71.

    Article  PubMed  Google Scholar 

  39. Thomas AC. Targeted treatments for restenosis and vein graft disease. ISRN Vasc Med. 2012;(2012): Article ID 710765, 23 pages. doi:10.5402/2012/710765.

    Google Scholar 

  40. Chen L, Theroux P, Lesperance J, Shabani F, Thibault B, DeGuise P. Angiographic features of vein grafts versus ungrafted coronary arteries inpatients with unstable angina and previous bypass surgery. J Am Coll Cardiol. 1996;28:1493–9.

    Article  CAS  PubMed  Google Scholar 

  41. Douglas Jr JS. Percutaneous approaches to recurrent myocardial ischemia in patients with prior surgical revascularization. Semin Thorac Cardiovasc Surg. 1994;6:98–108.

    PubMed  Google Scholar 

  42. Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, Rosenberg Y, Geller NL. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J Am Coll Cardiol. 2000;36(6):1877–83.

    Article  CAS  PubMed  Google Scholar 

  43. Singh SK, Desai ND, Petroff SD, Deb S, Cohen EA, Radhakrishnan S, Schwartz L, Dubbin J, Fremes SE. The impact of diabetic status on coronary artery bypass graft patency: insights from the radial artery patency study. Circulation. 2008;118(Suppl 1):S222–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana-Maria Ioan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cristian, G. et al. (2016). Mechanisms of Venous Graft Failure. In: Ţintoiu, I., Underwood, M., Cook, S., Kitabata, H., Abbas, A. (eds) Coronary Graft Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-26515-5_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26515-5_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26513-1

  • Online ISBN: 978-3-319-26515-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics